Epigenetic priming with decitabine followed by low-dose idarubicin/cytarabine has an increased anti-leukemic effect compared to traditional chemotherapy in high-risk myeloid neoplasms
| Image |  |
|---|---|
| Description | scientific article published on 13 October 2015 |
| Author/s |
author: Yinjun Lou |
| Publication date | October 13, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |